Parkwalk has launched the University of Oxford Innovation Fund VI (UOIF VI), the sixth fund in a decade long partnership with Oxford University Innovation (OUI).
The Oxford-based clinical-stage biopharmaceutical company that co-invented a COVID-19 vaccine is a spin-out from Oxford University’s Jenner Institute.
The challenge addresses two objectives: Be sustainable through green financing and investment, and Be mindful through products and services that raise awareness about our impact on the environment.
A rapid COVID-19 test developed at Oxford University is now being used at Heathrow and being trialled at Hong Kong International Airport to screen passengers.
Oxford University, through its research commercialisation arm Oxford University Innovation, has created PhishAR, its 200th spinout company.
Scientists from Oxford University’s Department of Physics have developed an extremely rapid diagnostic test that detects and identifies viruses in less than five minutes.